These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


204 related items for PubMed ID: 15343184

  • 1. Use of fecal elastase-1 to classify pancreatic status in patients with cystic fibrosis.
    Borowitz D, Baker SS, Duffy L, Baker RD, Fitzpatrick L, Gyamfi J, Jarembek K.
    J Pediatr; 2004 Sep; 145(3):322-6. PubMed ID: 15343184
    [Abstract] [Full Text] [Related]

  • 2. Pancreatitis among patients with cystic fibrosis: correlation with pancreatic status and genotype.
    De Boeck K, Weren M, Proesmans M, Kerem E.
    Pediatrics; 2005 Apr; 115(4):e463-9. PubMed ID: 15772171
    [Abstract] [Full Text] [Related]

  • 3. Faecal elastase-1 and fat-soluble vitamin profiles in patients with cystic fibrosis in Western Norway.
    Dorlöchter L, Aksnes L, Fluge G.
    Eur J Nutr; 2002 Aug; 41(4):148-52. PubMed ID: 12242582
    [Abstract] [Full Text] [Related]

  • 4. The changing face of the exocrine pancreas in cystic fibrosis: the correlation between pancreatic status, pancreatitis and cystic fibrosis genotype.
    Augarten A, Ben Tov A, Madgar I, Barak A, Akons H, Laufer J, Efrati O, Aviram M, Bentur L, Blau H, Paret G, Wilschanski M, Kerem BS, Yahav Y.
    Eur J Gastroenterol Hepatol; 2008 Mar; 20(3):164-8. PubMed ID: 18301294
    [Abstract] [Full Text] [Related]

  • 5. Comparison of monoclonal and polyclonal ELISAs for fecal elastase in patients with cystic fibrosis and pancreatic insufficiency.
    Borowitz D, Lin R, Baker SS.
    J Pediatr Gastroenterol Nutr; 2007 Feb; 44(2):219-23. PubMed ID: 17255835
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Faecal elastase-1 concentration in cystic fibrosis patients with CFTR I1234V mutation.
    Abdel Rahman H, Abdul Wahab A, Abdel Rahman MO, Mostafa OA.
    Acta Paediatr; 2006 Sep; 95(9):1066-9. PubMed ID: 16938751
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Evaluation of fecal pancreatic elastase-1 as a measure of pancreatic exocrine function in children with cystic fibrosis.
    Cade A, Walters MP, McGinley N, Firth J, Brownlee KG, Conway SP, Littlewood JM.
    Pediatr Pulmonol; 2000 Mar; 29(3):172-6. PubMed ID: 10686036
    [Abstract] [Full Text] [Related]

  • 10. [Relation between gene mutations and pancreatic exocrine function in patients with cystic fibrosis].
    Radivojević D, Guć-Sćekić M, Djurisić M, Lalić T, Minić P, Kanavakis E.
    Srp Arh Celok Lek; 2001 Mar; 129 Suppl 1():6-9. PubMed ID: 15637983
    [Abstract] [Full Text] [Related]

  • 11. A comparison of the efficacy and tolerance of pancrelipase and placebo in the treatment of steatorrhea in cystic fibrosis patients with clinical exocrine pancreatic insufficiency.
    Stern RC, Eisenberg JD, Wagener JS, Ahrens R, Rock M, doPico G, Orenstein DM.
    Am J Gastroenterol; 2000 Aug; 95(8):1932-8. PubMed ID: 10950038
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Evolution of pancreatic function during the first year in infants with cystic fibrosis.
    O'Sullivan BP, Baker D, Leung KG, Reed G, Baker SS, Borowitz D.
    J Pediatr; 2013 Apr; 162(4):808-812.e1. PubMed ID: 23245194
    [Abstract] [Full Text] [Related]

  • 14. [Measurement of fecal elastase 1 by immunoreactivity: a new indirect test of the pancreatic function].
    Stein J, Schoonbroodt D, Jung M, Lembcke B, Caspary WF.
    Gastroenterol Clin Biol; 1996 Apr; 20(5):424-9. PubMed ID: 8761139
    [Abstract] [Full Text] [Related]

  • 15. Low fecal elastase 1 levels do not indicate exocrine pancreatic insufficiency in type-1 diabetes mellitus.
    Hahn JU, Kerner W, Maisonneuve P, Lowenfels AB, Lankisch PG.
    Pancreas; 2008 Apr; 36(3):274-8. PubMed ID: 18362841
    [Abstract] [Full Text] [Related]

  • 16. An enteric-coated high-buffered pancrelipase reduces steatorrhea in patients with cystic fibrosis: a prospective, randomized study.
    Brady MS, Garson JL, Krug SK, Kaul A, Rickard KA, Caffrey HH, Fineberg N, Balistreri WF, Stevens JC.
    J Am Diet Assoc; 2006 Aug; 106(8):1181-6. PubMed ID: 16863712
    [Abstract] [Full Text] [Related]

  • 17. Pancreatic enzyme therapy and clinical outcomes in patients with cystic fibrosis.
    Baker SS, Borowitz D, Duffy L, Fitzpatrick L, Gyamfi J, Baker RD.
    J Pediatr; 2005 Feb; 146(2):189-93. PubMed ID: 15689904
    [Abstract] [Full Text] [Related]

  • 18. Polyclonal versus monoclonal ELISA for the determination of fecal elastase 1: diagnostic value in cystic fibrosis and chronic pancreatic insufficiency.
    Miendje Y, Maisin D, Sipewa MJ, Deprez P, Buts JP, De Nayer P, Philippe M.
    Clin Lab; 2004 Feb; 50(7-8):419-24. PubMed ID: 15330510
    [Abstract] [Full Text] [Related]

  • 19. Screening for pancreatic exocrine insufficiency in patients with diabetes mellitus.
    Nunes AC, Pontes JM, Rosa A, Gomes L, Carvalheiro M, Freitas D.
    Am J Gastroenterol; 2003 Dec; 98(12):2672-5. PubMed ID: 14687815
    [Abstract] [Full Text] [Related]

  • 20. [Comparison of faecal lipase test and faecal elastase-1 test in the assessment of exocrine pancreatic function in cystic fibrosis].
    Walkowiak J, Herzig KH, Strzykala K, Lisowska A, Przyslawski J, Grzymislawski M, Krawczynski M.
    Med Wieku Rozwoj; 2003 Dec; 7(2):149-55. PubMed ID: 12878785
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 11.